Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Induction of marrow hypoxia by radioprotective agents

Journal Article · · Radiat. Res.; (United States)
DOI:https://doi.org/10.2307/3577415· OSTI ID:5716375
The ability of thiol and non-thiol radioprotectors to induce hypoxia was determined using the binding of (/sup 3/H)misonidazole by bone marrow cells as a measure of hypoxia. When administered at maximally radioprotective doses, four drugs (WR-2721, cysteamine, 5-hydroxytryptamine, and 16,16-dimethyl prostaglandin E2) significantly increased the amount of (/sup 3/H)misonidazole bound by marrow cells, while no significant increase in binding was observed with three other agents (endotoxin, AET, superoxide dimutase). Doses of WR-2721 previously shown to provide suboptimal radioprotection did not significantly increase /sup 3/H-misonidazole binding. These results suggest that the physiological effects of some radioprotectors, that is, their ability to induce marrow hypoxia, may contribute to their efficacy in vivo.
Research Organization:
Cross Cancer Institute, Edmonton, Alberta (Canada)
OSTI ID:
5716375
Journal Information:
Radiat. Res.; (United States), Journal Name: Radiat. Res.; (United States) Vol. 118:3; ISSN RAREA
Country of Publication:
United States
Language:
English